Irving-based hormone replacement therapy provider Biote goes public via a blank check company Friday, hoping a cash injection will be a springboard for accelerated growth as it aims for $166 million ...

biote said a voluntary recall of certain bioidentical hormone pellets in January created a temporary supply disruption that cut Q1 revenue by an estimated $1.7 million, added about $1.5 million of ...

IRVING, Texas--(BUSINESS WIRE)--Women who took testosterone via hormone pellets as part of bioidentical hormone replacement therapy (BHRT) had a 35.5% lower incidence of invasive breast cancer ...

COLUMBUS, GA, UNITED STATES, March 3, 2026 /EINPresswire.com/ — OBGYN Specialists of Columbus is helping women better understand Bioidentical Hormone Replacement ...

Biote Corp. (NASDAQ:BTMD) announced Monday that its wholly owned subsidiary, F.H. Investments, Inc., doing business as Asteria Health, has initiated a voluntary recall of certain lots of compounded ...

Irving-based hormone therapy firm Biote Corp. will buy back nearly $77 million in stock to settle a lawsuit filed by the company's founder. The money will go to Gary Donovitz, who founded the company ...

BioTE pellet therapy is a brief in-office procedure that typically takes only a few minutes. After confirming the appropriate dose and reviewing consent, the provider marks the insertion site, most ...